Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 Asia Pacific Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
4.1 Asia Pacific PCR Market by Country
4.2 Asia Pacific Immunoassay Market by Country
4.3 Asia Pacific NGS Market by Country
4.4 Asia Pacific Microbiology Culture Market by Country
4.5 Asia Pacific Mass Spectrometry Market by Country
4.6 Asia Pacific Rapid & Point of Care Market by Country
4.7 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Diagnostic Laboratories Market by Country
5.3 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country
Chapter 6. Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
6.2 Asia Pacific Clostridium Difficile (CD) Market by Country
6.3 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country
6.4 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
6.5 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
6.6 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country
6.7 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Antimicrobial Resistance Diagnostics Market by Country
7.1 China Antimicrobial Resistance Diagnostics Market
7.1.1 China Antimicrobial Resistance Diagnostics Market by Technology
7.1.2 China Antimicrobial Resistance Diagnostics Market by End-user
7.1.3 China Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Japan Antimicrobial Resistance Diagnostics Market
7.2.1 Japan Antimicrobial Resistance Diagnostics Market by Technology
7.2.2 Japan Antimicrobial Resistance Diagnostics Market by End-user
7.2.3 Japan Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 India Antimicrobial Resistance Diagnostics Market
7.3.1 India Antimicrobial Resistance Diagnostics Market by Technology
7.3.2 India Antimicrobial Resistance Diagnostics Market by End-user
7.3.3 India Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 South Korea Antimicrobial Resistance Diagnostics Market
7.4.1 South Korea Antimicrobial Resistance Diagnostics Market by Technology
7.4.2 South Korea Antimicrobial Resistance Diagnostics Market by End-user
7.4.3 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen
7.5 Singapore Antimicrobial Resistance Diagnostics Market
7.5.1 Singapore Antimicrobial Resistance Diagnostics Market by Technology
7.5.2 Singapore Antimicrobial Resistance Diagnostics Market by End-user
7.5.3 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen
7.6 Malaysia Antimicrobial Resistance Diagnostics Market
7.6.1 Malaysia Antimicrobial Resistance Diagnostics Market by Technology
7.6.2 Malaysia Antimicrobial Resistance Diagnostics Market by End-user
7.6.3 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen
7.7 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market
7.7.1 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
7.7.2 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
7.7.3 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
Unique Offerings 